Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 335,649 | 322,676 | 307,201 | 300,954 | 317,862 |
| Cost of Goods | 150,960 | 147,902 | 148,320 | 142,287 | 143,829 |
| Gross Profit | 184,689 | 174,774 | 158,881 | 158,667 | 174,033 |
| Operating Expenses | 109,832 | 115,269 | 103,902 | 102,858 | 103,564 |
| Operating Income | 75,817 | 60,407 | 55,299 | 56,096 | 71,298 |
| Interest Expense | 926 | 1,193 | 1,109 | 928 | 782 |
| Other Income | 480 | 436 | 506 | 450 | 419 |
| Pre-tax Income | 75,371 | 59,650 | 54,696 | 55,618 | 70,935 |
| Income Tax | 24,051 | 18,916 | 16,698 | 17,122 | 22,281 |
| Net Income Continuous | 51,320 | 40,734 | 37,998 | 38,496 | 48,654 |
| Minority Interests | 3 | -9 | -12 | -11 | -3 |
| Net Income | $51,317 | $40,743 | $38,010 | $38,507 | $48,657 |
| EPS Basic Total Ops | 0.47 | 0.37 | 0.34 | 0.34 | 0.43 |
| EPS Basic Continuous Ops | 0.47 | 0.37 | 0.34 | 0.34 | 0.42 |
| EPS Diluted Total Ops | 0.46 | 0.36 | 0.34 | 0.33 | 0.42 |
| EPS Diluted Continuous Ops | 0.46 | 0.36 | 0.33 | 0.33 | 0.41 |
| EBITDA(a) | $88,803 | $73,112 | $68,113 | $68,141 | $83,177 |